ARTICLE | Clinical News
Ontak denileukin diftitox regulatory update
June 30, 2008 7:00 AM UTC
FDA accepted for filing and granted priority review to an sBLA seeking full approval for Ontak to treat cutaneous T cell lymphoma (CTCL). The interleukin-2 (IL-2) plus diphtheria toxin fusion protein...